HST Global, Inc. (HSTC)
OTCMKTS · Delayed Price · Currency is USD
0.7000
0.00 (0.00%)
Jun 15, 2026, 9:30 AM EST
HST Global Market Cap
HST Global has a market cap or net worth of $99 million as of June 16, 2026. Its market cap has increased by 17,047.91% in one year.
Market Cap
99.00M
Enterprise Value
99.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.70
Market Cap Chart
Since May 12, 2008, HST Global's market cap has increased from 11.89M to 99.00M, an increase of 732.95%. That is a compound annual growth rate of 12.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 99.00M | -24.83% |
| Dec 9, 2025 | 131.71M | 224.37% |
| Dec 30, 2024 | 40.61M | 1,173.50% |
| Dec 26, 2023 | 3.19M | 406.25% |
| Dec 30, 2022 | 629.83K | 9.09% |
| Dec 21, 2021 | 577.34K | 88.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glorywin Entertainment Group | 343.05M |
| Northwest Biotherapeutics | 332.49M |
| Silence Therapeutics | 316.00M |
| Vaxart | 135.11M |
| NDT Pharmaceuticals | 106.90M |
| BioStem Technologies | 72.32M |
| Sangamo Therapeutics | 62.56M |
| Cell Source | 55.72M |